BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33125340)

  • 1. VEGF levels in patients with glioma: a systematic review and meta-analysis.
    Seyedmirzaei H; Shobeiri P; Turgut M; Hanaei S; Rezaei N
    Rev Neurosci; 2021 Feb; 32(2):191-202. PubMed ID: 33125340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.
    Schmidt NO; Westphal M; Hagel C; Ergün S; Stavrou D; Rosen EM; Lamszus K
    Int J Cancer; 1999 Feb; 84(1):10-8. PubMed ID: 9988225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-ASL perfusion correlates with VEGF expression and overall survival in glioma patients: Comparison of quantitative perfusion and pathology on accurate spatial location-matched basis.
    Pang H; Dang X; Ren Y; Zhuang D; Qiu T; Chen H; Zhang J; Ma N; Li G; Zhang J; Wu J; Feng X
    J Magn Reson Imaging; 2019 Jul; 50(1):209-220. PubMed ID: 30652410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
    Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of vascular endothelial growth factor and matrix metalloproteinase-9 proteins in patients with glioma.
    Ma C; Li Y; Zhang X; Zhao G; Xu H
    J Int Med Res; 2014 Feb; 42(1):198-204. PubMed ID: 24398760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms.
    Plate KH; Breier G; Weich HA; Mennel HD; Risau W
    Int J Cancer; 1994 Nov; 59(4):520-9. PubMed ID: 7525492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
    Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
    Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of pigment epithelium derived factor expression in glioma progression.
    Guan M; Yam HF; Su B; Chan KP; Pang CP; Liu WW; Zhang WZ; Lu Y
    J Clin Pathol; 2003 Apr; 56(4):277-82. PubMed ID: 12663639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid VEGF levels and angiogenic capacity as potential prognostic markers in patients with gliomas: a pilot study.
    Vera S; Sinning M; Vergara M; Lemus D; Rosas C
    J Neurooncol; 2019 Nov; 145(2):233-239. PubMed ID: 31624989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of [
    Rainer E; Wang H; Traub-Weidinger T; Widhalm G; Fueger B; Chang J; Zhu Z; Marosi C; Haug A; Hacker M; Li S
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2396-2403. PubMed ID: 30062604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression.
    Takano S; Tsuboi K; Tomono Y; Mitsui Y; Nose T
    Br J Cancer; 2000 Jun; 82(12):1967-73. PubMed ID: 10864205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis of glioma: evaluation of ultrastructural characteristics of microvessels and tubular bodies (Weibel-Palade) in endothelial cells and immunohistochemical findings with VEGF and p53 protein.
    Miyagami M; Katayama Y
    Med Mol Morphol; 2005 Mar; 38(1):36-42. PubMed ID: 16158178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain gliomas and growth factors: immunohistochemical, immunofluorescence, flow cytometry and RT-PCR profile in pediatric age.
    Taurone S; Spoletini M; Chiappetta C; Di Gioia C; Carletti R; Greco A; Agostinelli E; Ralli M; Giangaspero F; Artico M; Pastore FS; Scarpa S; Gobbi P; Di Liddo R
    J Biol Regul Homeost Agents; 2019 September-October,; 33(5):1451-1463. PubMed ID: 31507151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas.
    Jensen RL; Ragel BT; Whang K; Gillespie D
    J Neurooncol; 2006 Jul; 78(3):233-47. PubMed ID: 16612574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
    Kawai N; Lin W; Cao WD; Ogawa D; Miyake K; Haba R; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1870-8. PubMed ID: 24781871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vascular endothelial growth factor and p53 protein in association with neovascularization in human malignant gliomas.
    Miyagami M; Tazoe M; Nakamura S
    Brain Tumor Pathol; 1998; 15(2):95-100. PubMed ID: 10328546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Nodal suppresses angiogenesis and growth of human gliomas.
    Hueng DY; Lin GJ; Huang SH; Liu LW; Ju DT; Chen YW; Sytwu HK; Chang C; Huang SM; Yeh YS; Lee HM; Ma HI
    J Neurooncol; 2011 Aug; 104(1):21-31. PubMed ID: 21116837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.
    Lamszus K; Ulbricht U; Matschke J; Brockmann MA; Fillbrandt R; Westphal M
    Clin Cancer Res; 2003 Apr; 9(4):1399-405. PubMed ID: 12684411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
    Guo P; Xu L; Pan S; Brekken RA; Yang ST; Whitaker GB; Nagane M; Thorpe PE; Rosenbaum JS; Su Huang HJ; Cavenee WK; Cheng SY
    Cancer Res; 2001 Dec; 61(23):8569-77. PubMed ID: 11731444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.